VYNE - speculating a good quarter due to FDA approval

With FDA approval already and earning reports coming through, I expect a lot of speculation that the company will have people speculating a good quarter earnings report

back

VYNE - speculating a good quarter due to FDA approval

bullish

With FDA approval already and earning reports coming through, I expect a lot of speculation that the company will have people speculating a good quarter earnings report

Comments

Write your comment....

Sign in to comment

read-time
< 1 min

3.05

Target Price

8/ 10

Confidence

2-4 Weeks

Timeframe
Share
catalyst icon
Earnings Release
catalyst icon
News
catalyst icon
SEC Filing
catalyst icon
Sentiment
catalyst icon
Other Catalyst

VYNE Channel

Start new chat
aiodd-ad
next